Perioperative use of prothrombin complex concentrates.

作者: Llau Jv , Garutti I , Díez Lobo A , Pita E , Gómez-Luque A

DOI:

关键词:

摘要: Prothrombin complex concentrates (PCCs) are purified drug products with hemostatic activity derived from a plasma pool. Today, PCCs contain given and proportional amount of four non-activated vitamin K-dependent coagulation factors (II, VII, IX, X), variable anticoagulant proteins (proteins C S, in some antithrombin) low-dose heparin. In countries PCC contained only three clotting factors, II, X. Dosage recommendations based on IU F-IX, so that one F-IX represents the 1 mL plasma. Reversion effect K antagonists (VKAs) cases symptomatic overdose, active bleeding episodes, or need for emergency surgery is most important indication this appears to be more complete rapid than caused by administration fresh frozen They may considered as safe preparations if they used their approved indications at recommended dosage adequate precautions administration, have been shown effective reversing VKAs. Their use decision algorithms perioperative setting allows normalization International Normalized Ratio (INR) performing surgery, minimizing risk. This review aims propose two setting, calculate dose administered patient and/or immediately before urgent patient's clinical status, prior INR target another action oral anticoagulants depending urgency surgery.

参考文章(90)
Paul C Hébert, George Wells, Morris A Blajchman, John Marshall, Claudio Martin, Giuseppe Pagliarello, Martin Tweeddale, Irwin Schweitzer, Elizabeth Yetisir, Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group, A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care The New England Journal of Medicine. ,vol. 340, pp. 409- 417 ,(1999) , 10.1056/NEJM199902113400601
Bellal Joseph, Albert Amini, Randall S. Friese, Matthew Houdek, Daniel Hays, Narong Kulvatunyou, Julie Wynne, Terence OʼKeeffe, Rifat Latifi, Peter Rhee, Factor IX complex for the correction of traumatic coagulopathy. Journal of Trauma-injury Infection and Critical Care. ,vol. 72, pp. 828- 834 ,(2012) , 10.1097/TA.0B013E318247C944
Rachana Kumar, Suzette Béguin, H Coenraad Hemker, The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin. Thrombosis and Haemostasis. ,vol. 72, pp. 713- 721 ,(1994) , 10.1055/S-0038-1648947
David J. Perry, Factor VII Deficiency. British Journal of Haematology. ,vol. 118, pp. 689- 700 ,(2002) , 10.1046/J.1365-2141.2002.03545.X
Alfred Ian Lee, Federico Campigotto, James D. Rawn, Donna Neuberg, Richard M. Kaufman, Nancy Berliner, Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients British Journal of Haematology. ,vol. 157, pp. 397- 400 ,(2012) , 10.1111/J.1365-2141.2011.08992.X
Rustam Al‐Shahi Salman, Zhe Kang Law, Philip M Bath, Thorsten Steiner, Nikola Sprigg, Haemostatic therapies for acute spontaneous intracerebral haemorrhage Cochrane Database of Systematic Reviews. ,vol. 4, ,(2009) , 10.1002/14651858.CD005951.PUB3
Ingrid Pabinger, , Andreas Tiede, Uwe Kalina, Sigurd Knaub, Reinhard Germann, Helmut Ostermann, Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate Annals of Hematology. ,vol. 89, pp. 309- 316 ,(2010) , 10.1007/S00277-009-0830-7